Elixinol Wellness Limited (ELLXF)

USD 0.01

(22.5%)

Annual Income Statements

(In AUD)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue 8.26 Million 7.05 Million 9.33 Million 15.01 Million 27.18 Million 37.13 Million
Cost of Revenue 4.84 Million 3.81 Million 4.44 Million 8.34 Million 11.56 Million 17.17 Million
Gross Profit 3.42 Million 3.23 Million 4.89 Million 6.66 Million 15.61 Million 19.95 Million
Operating Expenses 3.42 Million 13.24 Million 20.5 Million 31.99 Million 39.38 Million 20.93 Million
Selling, General and Administrative Expenses 7.98 Million 10.36 Million 16.63 Million 24.71 Million 31.98 Million 18.17 Million
Research and Development Expenses - - - - - -
Other Expenses - 472 Thousand 2.5 Million 522 Thousand 88 Thousand 734 Thousand
Cost and Expenses 14.25 Million 17.05 Million 24.94 Million 40.33 Million 50.94 Million 38.1 Million
Operating Income -5.99 Million -9.01 Million -11.66 Million 49.12 Million -24.74 Million -974 Thousand
Interest Expense 101 Thousand 71 Thousand 92 Thousand 49 Thousand 121 Thousand -
Income Tax Expense 3000.00 2000.00 -65 Thousand 4.2 Million -7.2 Million 363 Thousand
Earnings before Tax -7.5 Million -10.56 Million -17.09 Million -100.27 Million -73.61 Million -497 Thousand
Net Income -7.5 Million -10.57 Million -17.02 Million -104.5 Million -83.34 Million -860 Thousand
Earnings Per Share Basic -0.02 -0.03 -0.04 -0.45 -0.42 -0.01
Earnings Per Share Diluted -0.02 -0.03 -0.04 -0.45 -0.42 -0.01
Weighted Average Shares Outstanding 472.13 Million 406.38 Million 404.76 Million 230.68 Million 196.99 Million 125.36 Million
Weighted Average Shares Outstanding (Diluted) 473.41 Million 406.38 Million 404.76 Million 230.68 Million 196.99 Million 125.36 Million
Gross Margin 0.41 0.46 0.52 0.44 0.57 0.54
EBIT Margin -0.83 -1.18 -1.09 3.49 -0.82 -0.00
Profit Margin -0.91 -1.50 -1.82 -6.96 -3.07 -0.02
EBITDA -6.83 Million -9.28 Million -14.11 Million -22.11 Million -22.29 Million -150 Thousand
Earnings Before Tax Margin -0.72 -1.28 -1.25 3.27 -0.91 -0.03

Income Statement Charts